| Preview | Issue Date | Title | Author(s) |
| 2009 | A Peptide Antagonist of the TLR4-MD2 Interaction | Slivka, P.; Shridhar, M.; Lee, G.; Sammond, D.; Hutchinson, M.; Martinko, A.; Buchanan, M.; Sholar, P.; Kearney, J.; Harrison, J.; Watkins, L.; Yin, H. |
| 2010 | Application of a novel in silico high-throughput screen to identify selective inhibitors for protein-protein interactions | Joce, C.; Stahl, J.; Shridhar, M.; Hutchinson, M.; Watkins, L.; Fedichev, P.; Yin, H. |
| 2017 | Constriction of the buccal branch of the facial nerve produces unilateral craniofacial allodynia | Lewis, S.; Grace, P.; Hutchinson, M.; Maier, S.; Watkins, L. |
| 2010 | Evidence that intrathecal morphine-3-glucuronide may cause pain enhancement via toll-like receptor 4/MD-2 and interleukin-1beta | Lewis, S.; Hutchinson, M.; Rezvani, N.; Loram, L.; Zhang, Y.; Maier, S.; Rice, K.; Watkins, L. |
| 2010 | Evidence that tricyclic small molecules may possess toll-like receptor and myeloid differentiation protein 2 activity | Hutchinson, M.; Loram, L.; Zhang, Y.; Shridhar, M.; Rezvani, N.; Berkelhammer, D.; Phipps, S.; Foster, P.; Landgraf, K.; Falke, J.; Rice, K.; Maier, S.; Yin, H.; Watkins, L. |
| 2011 | Exploring the neuroimmunopharmacology of opioids: An integrative review of mechanisms of central immune signaling and their implications for opioid analgesia | Hutchinson, M.; Shavit, Y.; Grace, P.; Rice, K.; Maier, S.; Watkins, L.; Barker, E.L. |
| 2012 | Inhibiting the TLR4-MyD88 signalling cascade by genetic or pharmacological strategies reduces acute alcohol-induced sedation and motor impairment in mice | Wu, Y.; Lousberg, E.; Moldenhauer, L.; Hayball, J.; Coller, J.; Rice, K.; Watkins, L.; Somogyi, A.; Hutchinson, M. |
| 2007 | 'Listening' and 'talking' to neurons: Implications of immune activation for pain control and increasing the efficacy of opioids | Watkins, L.; Hutchinson, M.; Milligan, E.; Maier, S. |
| 2008 | Minocycline suppresses morphine-induced respiratory depression, suppresses morphine-induced reward, and enhances systemic morphine-induced analgesia | Hutchinson, M.; Northcutt, A.; Chao, L.; Kearney, J.; Zhang, Y.; Berkelhammer, D.; Loram, L.; Rozeske, R.; Bland, S.; Gleeson, T.; Watkins, L.; Maier, S. |
| 2012 | Morphine activates neuroinflammation in a manner parallel to endotoxin | Wang, X.; Loram, L.; Ramos, K.; de Jesus, A.; Thomas, J.; Cheng, K.; Reddy, A.; Somogyi, A.; Hutchinson, M.; Watkins, L.; Yin, H. |
| 2011 | Naloxone-precipitated morphine withdrawal behavior and brain IL-1β expression: Comparison of different mouse strains | Liu, L.; Coller, J.; Watkins, L.; Somogyi, A.; Hutchinson, M. |
| 2010 | Possible involvement of toll-like receptor 4/myeloid differentiation factor-2 activity of opioid inactive isomers causes spinal proinflammation and related behavioral consequences | Hutchinson, M.; Lewis, S.; Coats, B.; Rezvani, N.; Zhang, Y.; Wieseler, J.; Somogyi, A.; Yin, H.; Maier, S.; Rice, K.; Watkins, L. |
| 2008 | Proinflammatory cytokines oppose opioid-induced acute and chronic analgesia | Hutchinson, M.; Coats, B.; Lewis, S.; Zhang, Y.; Sprunger, D.; Rezvani, N.; Baker, E.; Jekich, B.; Wieseler-Frank, J.; Somogyi, A.; Martin, D.; Poole, S.; Judd, C.; Maier, S.; Watkins, L. |
| 2009 | Reduction of opioid withdrawal and potentiation of acute opioid analgesia by systemic AV411 (ibudilast) | Hutchinson, M.; Lewis, S.; Coats, B.; Skyba, D.; Crysdale, N.; Berkelhammer, D.; Brzeski, A.; Northcutt, A.; Vietz, C.; Judd, C.; Maier, S.; Watkins, L.; Johnson, K. |
| 2015 | Targeting the toll of drug abuse: the translational potential of toll-like receptor 4 | Bachtell, R.; Hutchinson, M.; Wang, X.; Rice, K.; Maier, S.; Watkins, L. |
| 2009 | The cortical innate immune response increases local neuronal excitability leading to seizures | Rodgers, K.; Hutchinson, M.; Northcutt, A.; Maier, S.; Watkins, L.; Barth, D. |
| 2013 | The future: new concepts and potential therapies | Sumracki, N.; Nicotra, L.; Kwok, Y.; Liu, L.; Steeg, K.; Watkins, L.; Hutchinson, M.; Toth, C.; Moulin, D. |
| 2009 | The glial activation inhibitor AV411 reduces morphine-induced nucleus accumbens dopamine release | Bland, S.; Hutchinson, M.; Maier, S.; Watkins, L.; Johnson, K. |
| 2010 | Toll-like receptor 4 in CNS pathologies | Buchanan, M.; Hutchinson, M.; Watkins, L.; Yin, H. |
